EntryPoint Capital’s SI-BONE Inc SIBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$330K Buy
+20,237
New +$289K 0.08% 503
2025
Q3
Sell
-13,827
Closed -$260K 852
2025
Q2
$260K Sell
13,827
-960
-6% -$15.9K 0.13% 352
2025
Q1
$207K Buy
14,787
+2,613
+21% +$42.2K 0.1% 514
2024
Q4
$171K Buy
+12,174
New +$164K 0.07% 619
2024
Q3
Sell
-8,038
Closed -$104K 1256
2024
Q2
$104K Sell
8,038
-5,868
-42% -$83.8K 0.05% 800
2024
Q1
$228K Buy
13,906
+6,113
+78% +$115K 0.2% 78
2023
Q4
$164K Buy
+7,793
New +$144K 0.16% 152

Other funds holding SIBN

EntryPoint Capital's SIBN Position: Q2 2026 in Review

EntryPoint Capital opened a new position in SI-BONE Inc (SIBN) in Q2 2026: 20,237 shares worth $330K. The stake represents 0.08% of the portfolio and ranks #503 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in SIBN as recently as Q2 2025.

EntryPoint Capital first reported a position in SIBN in Q4 2023 and has held it in 7 quarters since. 168 funds tracked by Wall St. Rank hold SIBN as of Q2 2026.

  • EntryPoint Capital held 20,237 shares of SI-BONE Inc worth $330K as of Q2 2026.
  • SI-BONE Inc was a new EntryPoint Capital position in Q2 2026.
  • SI-BONE Inc made up 0.08% of EntryPoint Capital's portfolio in Q2 2026, its #503 holding.
  • EntryPoint Capital first reported a position in SI-BONE Inc in Q4 2023 and has held it in 7 quarters since.
  • 168 funds tracked by Wall St. Rank held SI-BONE Inc as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.